DSP Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • 0.72 %Nav, as on 23-04-2025

  • Previous Nav

  • Net Change on 23-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
DSP Healthcare Fund - Direct Plan - Growth -0.07 -5.32 20.31 21.79 26.58 25.05
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 20.31 21.79 26.58 0.63 3,018.76
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 19.87 20.86 23.70 0.91 8,080.97
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 25.47 25.08 26.79 1.18 4,914.64
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 25.35 24.93 26.66 0.90 3,610.51
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 23.51 20.04 24.96 0.61 2,667.40
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 21.90 21.87 24.17 0.72 1,183.65

Fund Holdings as on 31-March-2025

  • Sun Pharmaceutical Industries Limited

  • Suven Pharmaceuticals Limited

  • Cipla Limited

  • IPCA Laboratories Limited

  • Globus Medical Inc

  • Gland Pharma Limited

  • Laurus Labs Limited

  • Alembic Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • Sai Life Sciences Limited

  • Illumina Inc

  • Vijaya Diagnostic Centre Limited

  • Kovai Medical Center and Hospital Limited

  • Concord Biotech Limited

  • Procter & Gamble Health Limited

  • Pfizer Limited

  • Intuitive Surgical Inc

  • Indoco Remedies Limited

  • Unichem Laboratories Limited

  • Narayana Hrudayalaya Ltd.

  • ICICI Lombard General Insurance Company Limited

  • TREPS / Reverse Repo Investments

  • Emcure Pharmaceuticals Limited

  • Abbott Laboratories

  • Aarti Drugs Limited

  • Alkem Laboratories Limited

  • Global X Funds - Global X Genomics & Biotechnology ETF

  • Thyrocare Technologies Limited

  • Jupiter Life Line Hospitals Limited

  • Medplus Health Services Limited

  • Laxmi Dental Limited

  • Grail Inc

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹3,018.76 crore. DSP Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of DSP Healthcare Fund ended up ₹0.3(0.72%)yesterday to ₹41.812.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The DSP Healthcare Fund is managed by Chirag Dagli .

Fund House Contact

Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021

+91 (22) 66578000
service@dspim.com
+91 (22) 66578181